Potkrajcic, V.; Gani, C.; Fischer, S.G.; Boeke, S.; Niyazi, M.; Thorwarth, D.; Voigt, O.; Schneider, M.; Mönnich, D.; Kübler, S.;
et al. Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation. Curr. Oncol. 2024, 31, 2679-2688.
https://doi.org/10.3390/curroncol31050203
AMA Style
Potkrajcic V, Gani C, Fischer SG, Boeke S, Niyazi M, Thorwarth D, Voigt O, Schneider M, Mönnich D, Kübler S,
et al. Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation. Current Oncology. 2024; 31(5):2679-2688.
https://doi.org/10.3390/curroncol31050203
Chicago/Turabian Style
Potkrajcic, Vlatko, Cihan Gani, Stefan Georg Fischer, Simon Boeke, Maximilian Niyazi, Daniela Thorwarth, Otilia Voigt, Moritz Schneider, David Mönnich, Sarah Kübler,
and et al. 2024. "Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation" Current Oncology 31, no. 5: 2679-2688.
https://doi.org/10.3390/curroncol31050203
APA Style
Potkrajcic, V., Gani, C., Fischer, S. G., Boeke, S., Niyazi, M., Thorwarth, D., Voigt, O., Schneider, M., Mönnich, D., Kübler, S., Boldt, J., Hoffmann, E., Paulsen, F., Mueller, A.-C., & Wegener, D.
(2024). Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation. Current Oncology, 31(5), 2679-2688.
https://doi.org/10.3390/curroncol31050203
